Skip to content
  • Français
Canadian Drug Policy Coalition
  • About
    • About
    • Vision & Mission
    • Our Staff
    • Steering Committee
    • Contact Us
    • Jobs
  • Our Work
    • Case for Reform
    • Imagine Safe Supply
    • To End a Crisis: Vision for BC Drug Policy
    • Getting to Tomorrow
    • Publications & Submissions
    • Advocacy
  • Issues
    • Legal Regulation
    • Decriminalization
    • Harm Reduction
    • Heroin Assisted Treatment
    • Psychedelics
  • News & Updates
    • Blog
    • Press Release
    • In The News
    • Media Contact
  • Resources
    • Report on Canadian Drug Policy
    • History of Drug Policy in Canada
    • Drug Policy and Racism
    • Advocacy Resources
    • Critical Terminology Guide
    • Avoiding Stigmatizing Language
    • Evidence & Data
    • COVID-19
  • Take Action
    • Donate
    • Newsletter
    • Join the Coalition

Category: covid research

Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators

April 24, 2020 (April 25, 2020)
By Canadian Drug Policy Coalition

class exemption for supervised consumption sites class exemption for supervised consumption sites Click HERE for more resources “Health Canada proactively issued class exemptions to provinces and territories…

Read More

Policing the Pandemic: Tracking the Policing of Covid-19 across Canada

April 19, 2020 (April 25, 2020)
By Canadian Drug Policy Coalition

The Policing the Pandemic Mapping Project was launched to track and visualize the massive and extraordinary expansions of police power in response to the COVID-19 Pandemic and the unequal patterns of enforcement that may arise as a result.

Read More

Rights in the time of COVID-19: Lessons from HIV for an effective, community-led response

April 6, 2020 (April 25, 2020)
By Canadian Drug Policy Coalition

In times of fear and panic, some countries may resort to politically-driven, restrictive, stigmatizing and punitive measures

Read More

Expanding access to diacetylmorphine & hydromorphone in Canada

April 2, 2020 (April 19, 2020)
By Canadian Drug Policy Coalition

Click HERE for more resources Abstract: The increasing incidence of fatal opioid overdose is a public health crisis in Canada. While buprenorphine/naloxone and methadone are the standard…

Read More

FAQ: Class Exemption for Controlled Substances during COVID-19

March 23, 2020 (April 17, 2020)
By Canadian Drug Policy Coalition

In response to this evolving health risk, the Office of Controlled Substances has issued a short-term subsection 56(1) exemption from the Controlled Drugs and Substances Act in the public interest.

Read More

CDSA Exemption and Interpretive Guide for Controlled Substances

March 20, 2020 (April 17, 2020)
By Canadian Drug Policy Coalition

“We strongly encourage all partners to work to implement these exemptions in their jurisdictions
and welcome any additional suggestions you may have to maintain Canadians’ access to
controlled substances for medical reasons during the pandemic.”

Read More
  • «
  • 1
  • 2

The Canadian Drug Policy Coalition is based out of Simon Fraser University’s Faculty of Health Sciences.

Sign up for latest news and updates

Canadian Drug Policy Coalition © 2025.
  • Disclaimer
  • Twitter
  • Facebook
  • Instagram